Galmed Pharmaceuticals Total Debt vs. Book Value Per Share
| GLMD Stock | USD 2.68 0.02 0.74% |
For Galmed Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Galmed Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Galmed Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Galmed Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Galmed Pharmaceuticals over time as well as its relative position and ranking within its peers.
Galmed |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Galmed Pharmaceuticals. If investors know Galmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Galmed Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Galmed Pharmaceuticals is measured differently than its book value, which is the value of Galmed that is recorded on the company's balance sheet. Investors also form their own opinion of Galmed Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Galmed Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Galmed Pharmaceuticals' market value can be influenced by many factors that don't directly affect Galmed Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Galmed Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Galmed Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Galmed Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Galmed Pharmaceuticals Book Value Per Share vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Galmed Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Galmed Pharmaceuticals value to that of its competitors to determine the firm's financial worth. Galmed Pharmaceuticals is rated below average in total debt category among its peers. It is one of the top stocks in book value per share category among its peers . The ratio of Total Debt to Book Value Per Share for Galmed Pharmaceuticals is about 1,242 . At present, Galmed Pharmaceuticals' Book Value Per Share is projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Galmed Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Galmed Total Debt vs. Competition
Galmed Pharmaceuticals is rated below average in total debt category among its peers. Total debt of Health Care industry is currently estimated at about 496.15 Million. Galmed Pharmaceuticals adds roughly 41,000 in total debt claiming only tiny portion of equities under Health Care industry.
Galmed Book Value Per Share vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Galmed Pharmaceuticals |
| = | 41 K |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Galmed Pharmaceuticals |
| = | 33.01 X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Galmed Book Value Per Share Comparison
Galmed Pharmaceuticals is currently under evaluation in book value per share category among its peers.
Galmed Pharmaceuticals Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Galmed Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Galmed Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Galmed Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Galmed Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -408.6 K | -388.2 K | |
| Operating Income | 6.7 M | 7.1 M | |
| Income Before Tax | -6.2 M | -6.5 M | |
| Total Other Income Expense Net | -13 M | -12.3 M | |
| Net Loss | -6.2 M | -6.5 M | |
| Income Tax Expense | -13.5 M | -12.8 M | |
| Net Loss | -6.8 M | -7.1 M | |
| Net Loss | -25.9 M | -24.6 M | |
| Net Interest Income | 856.8 K | 775.1 K | |
| Interest Income | 431.2 K | 747.7 K | |
| Change To Netincome | 1.6 M | 2.2 M | |
| Net Loss | (34.56) | (36.29) | |
| Income Quality | 0.80 | 0.67 | |
| Net Income Per E B T | 1.20 | 1.09 |
Galmed Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Galmed Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Galmed Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Galmed Pharmaceuticals' important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Galmed Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
| All Next | Launch Module |
Use Investing Themes to Complement your Galmed Pharmaceuticals position
In addition to having Galmed Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Recreation Thematic Idea Now
Recreation
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Recreation theme has 34 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recreation Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis. For information on how to trade Galmed Stock refer to our How to Trade Galmed Stock guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
To fully project Galmed Pharmaceuticals' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Galmed Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Galmed Pharmaceuticals' income statement, its balance sheet, and the statement of cash flows.